Alembic FY26 Net Profit Rises; Board Recommends Dividend
Alembic Limited's FY26 consolidated net profit after tax and share of associate's profit rose to Rs 31,738 lakh from Rs 31,068 lakh in FY25. Revenue from operations for the year increased to Rs 23,999 lakh. The board recommended a dividend of Rs 2.40 per share, subject to shareholder approval.
*this image is generated using AI for illustrative purposes only.
Alembic Limited reported its audited financial results for the quarter and financial year ended March 31, 2026. The company's consolidated net profit after tax and share of associate's profit stood at Rs 6,713 lakh for the fourth quarter, a decrease from Rs 6,845 lakh in the corresponding period of the previous year. Revenue from operations for the quarter remained relatively steady at Rs 6,004 lakh compared to Rs 6,027 lakh in the same quarter last year.
Key Financial Performance
The board approved the audited financial results and recommended a dividend of Rs 2.40 per equity share, representing 120% of the face value of Rs 2/- each, for the fiscal year ended March 31, 2026. This dividend is subject to shareholder approval at the ensuing Annual General Meeting.
For the full financial year, the company reported a consolidated net profit after tax and share of associate's profit of Rs 31,738 lakh, compared to Rs 31,068 lakh in the previous year. Total revenue from operations for the year increased to Rs 23,999 lakh from Rs 22,189 lakh in FY25.
Consolidated Financial Highlights
The following table summarizes the key consolidated financial metrics for the quarter and year ended March 31, 2026:
| Metric | Q4 FY26 (Rs in Lakhs) | Q4 FY25 (Rs in Lakhs) | Year Ended FY26 (Rs in Lakhs) | Year Ended FY25 (Rs in Lakhs) |
|---|---|---|---|---|
| Revenue from Operations | 6,004 | 6,027 | 23,999 | 22,189 |
| Total Income | 6,218 | 6,323 | 31,296 | 29,678 |
| Net Profit after Tax | 961 | 2,375 | 12,593 | 14,457 |
| Share of Associate's Profit | 5,752 | 4,470 | 19,145 | 16,610 |
| Net Profit after Tax & Share of Associate | 6,713 | 6,845 | 31,738 | 31,068 |
Segment Performance
The company operates primarily in two segments: Active Pharmaceutical Ingredients (API) and Real Estate. For the quarter ended March 31, 2026, the Real Estate business contributed significantly to revenue with Rs 5,021 lakh, while the API business reported revenue of Rs 983 lakh. For the full year, Real Estate revenue stood at Rs 19,340 lakh, and API revenue was Rs 4,659 lakh.
The statutory auditors, M/s. CNK & Associates LLP, issued an unmodified opinion on the consolidated and standalone financial results for the year ended March 31, 2026.
Historical Stock Returns for Alembic
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.08% | -4.38% | -6.86% | -11.34% | -21.05% | -34.01% |
How might Alembic Limited's heavy reliance on Real Estate revenue (over 80% of total) impact its long-term growth strategy if the property market faces a downturn?
Given the significant decline in standalone net profit after tax (from Rs 14,457 lakh to Rs 12,593 lakh), what cost optimization or revenue diversification measures is management likely to pursue in FY27?
With the API segment contributing only Rs 4,659 lakh annually versus Real Estate's Rs 19,340 lakh, could Alembic Limited consider divesting or restructuring its pharmaceutical operations to focus on its core real estate business?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
